Vasoplegia: Clinical Trials

45 trials for Vasoplegia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 10 unknown, 8 recruiting, 5 not yet recruiting. 9 Phase 3, 7 Not applicable, 6 Phase 4, 5 Phase 2, 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 39Completed 3, Active not recruiting 2, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Not applicable7Unknown 3, Not yet recruiting 2, Completed 1, Recruiting 1
Phase 46Completed 2, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Phase 25Completed 2, Active not recruiting 1, Terminated 1, Withdrawn 1
Early Phase 12Completed 1, Unknown 1

Follow Vasoplegia: new trials by email Literature Review of Vasoplegia trials Research Report on Vasoplegia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Hemoadsorption on Vascular Integrity in Septic Shock
CytoSorb hemoadsorption, Standard Medical Therapy (SMT) - Septic Shock
Not applicableNot yet recruitingSemmelweis University1102026-09-012026-07-17
Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock
Dexmedetomidine 100 µg/mL, intravenous solution, Stardard care - Septic Shock, Vasopressor Resistance
Phase 3Not yet recruitingHospices Civils de Lyon3602026-09-012026-05-06
Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)
Angiotensin II (Giapreza®) - Vasoplegic Shock, Cardiopulmonary Bypass
Phase 4Not yet recruitingMethodist Healthcare System of San Antonio3292026-07-012026-06-26
GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Analyses, and Pre- and Intraoperative Clinical Data - to Predict Early Complications After Cardiac Surgery.
Multi-Omics Data and Clinical Data Collection - Postoperative Delirium (POD), Postoperative Bleeding
Not yet recruitingMedical University of Gdansk30002026-01-012026-01-15
Effect Inhaled Nitric Oxide in Adult Liver Transplant
Prospective iNO Administration ("After" Group), No Intervention Retrospective "Before" Group - Liver Diseases, Reperfusion Injury
Not applicableNot yet recruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2602025-09-012025-08-15
Femoral Versus Radial Invasive Arterial Pressure Monitoring in Cardiac Surgery Patients
Femoral artery catheterization for continuous invasive arterial blood pressure monitoring, Radial artery catheterization for continuous invasive arterial blood pressure monitoring - Vasoplegia Syndrome, Vasoplegia
Not applicableRecruitingGuillaume BESCH3402025-06-152025-12-22
Reducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin II
Angiotensin II, Noradrenalin - Cardiac Surgery, Vasoplegia
Phase 3RecruitingUniversität Münster10222025-03-312025-07-18
Evaluation of the HPA Axis in Patients With Vasoplegic Syndrome After Cardiac Surgery
Blood sampling, Vital status - Vasoplegic Syndrome in Adult Cardiac Surgery
RecruitingAssistance Publique - Hôpitaux de Paris2002025-03-052026-01-30
Angiotensin II Stress Test. Renin Kinetics During Treatment of Vasoplegic Shock With Angiotensin II.
Shock, Vasoplegic Syndrome
RecruitingUniversity Medical Centre Maribor1212024-08-012026-09-16
Characterisation of Endothelial Cells in Different Inflammatory Pathologies
Endothelial cell biopsy - Sepsis, Vasoplegia
RecruitingRoyal Surrey County Hospital NHS Foundation Trust1052024-07-162024-09-25
Effects of Vitamin C on Shock Duration and Microcirculation in Patients With Vasoplegia Syndrome After Cardiac Surgery
Vit C, Standard Preparation - Vasoplegia Syndrome
Not applicableCompletedSoutheast University, China402024-07-012026-09-16
In Situ Exploration of Vascular Function in Vasoplegic Shock Following Cardiac Surgery With Cardiopulmonary Bypass
Cardiac Surgical Procedures
UnknownUniversity Hospital, Rouen1242024-02-052024-03-19
Occult Vasoplegia in Normotensive Sepsis: Early Prediction With Diastolic Index and Lactate
Sepsis, Vasoplegia
CompletedHospital H+ Queretaro5262024-01-012026-06-18
Endotoxinemia and Vasoplegia Following Cardiothoracic Surgery With Cardiopulmonary Bypass (CPB)
Patients with cardiopulmonary bypass - Vasoplegia, Vasoplegic Shock
UnknownUniversität Münster2002023-10-022023-12-11
Norepinephrine Weaning Guided by the Hypotension Prediction Index in Vasoplegic Shock After Cardiac Surgery
norepinephrine weaning protocol, norepinephrine weaning protocol and guided by the HPI - Vasoplegia, Shock
Not applicableUnknownCentre Hospitalier Universitaire, Amiens1422023-09-012024-07-03
Differential Regulation of RAAS-axis in Patients Undergoing Cardiac Surgery
on-pump surgery, off-pump surgery - Vasoplegia, Vasoplegic Shock
RecruitingUniversität Münster402023-08-242024-12-12
POLECAT: Perioperative Delta Renin Concentration
Post Operative Vasoplegic Syndrome, Acute Kidney Injury
UnknownRoyal Surrey County Hospital NHS Foundation Trust4052023-07-012023-07-12
Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation
Vasopressin, Norepinephrine, Collection of clinical data - Scheduled Cardiac Surgery With Extracorporeal Circulation, Vasoplegic Syndrome
Phase 3Active not recruitingCentre Hospitalier Universitaire Dijon8402023-01-022025-12-22
Reperfusion Syndrome and Vasoplegic Syndrome in Liver Transplant Surgery
noradrenaline/adrenaline - Postperfusion Syndrome
CompletedHospital Universitari Vall d'Hebron Research Institute2462022-12-132023-02-21
Angiotensin II in Liver Transplantation
Angiotensin II, Saline - Liver Transplant; Complications, Vasoplegia
Phase 2 / Phase 3Active not recruitingUniversity of California, San Francisco502022-06-282026-03-20

Showing 20 of 45. Sign in to see all of them.

Narrower conditions

Shock, Septic (7)  ·  Acute Kidney Injury (6)  ·  Sepsis (6)  ·  Shock (5)  ·  Hypotension (4)  ·  Fibrosis (2)  ·  Shock, Cardiogenic (2)  ·  Acute-On-Chronic Liver Failure (1)  ·  Atrial Fibrillation (1)  ·  Burns (1)  ·  Cardiovascular Diseases (1)  ·  Communicable Diseases (1)  ·  Coronary Artery Disease (1)  ·  Critical Illness (1)

Broader conditions

Pathologic Processes (45)  ·  Pathological Conditions, Signs and Symptoms (45)  ·  Vascular Diseases (45)  ·  Cardiovascular Diseases (44)  ·  Postoperative Complications (44)  ·  Inflammation (9)  ·  Infections (8)  ·  Systemic Inflammatory Response Syndrome (8)  ·  Shock (7)  ·  Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Kidney Diseases (6)  ·  Male Urogenital Diseases (6)  ·  Renal Insufficiency (6)  ·  Urogenital Diseases (6)

Interventions

Angiotensin II (5)  ·  Hydroxocobalamin (4)  ·  Norepinephrine (4)  ·  Ascorbic Acid (3)  ·  Giapreza (3)  ·  Methylene Blue (3)  ·  Saline Solution (3)  ·  Hydrocortisone (2)  ·  Midodrine (2)  ·  Sodium Chloride (2)  ·  Vitamin B 12 (2)  ·  Blood Specimen Collection (1)  ·  Bupivacaine (1)  ·  Cardiopulmonary Bypass (1)  ·  Dexmedetomidine (1)

Sponsors

Centre Hospitalier Universitaire, Amiens (6)  ·  Universität Münster (4)  ·  Mayo Clinic (3)  ·  Royal Surrey County Hospital NHS Foundation Trust (2)  ·  Ain Shams University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Austin Health (1)  ·  Australian and New Zealand Intensive Care Research Centre (1)  ·  Beijing Anzhen Hospital (1)  ·  Bürgerspital Solothurn (1)  ·  Centre Hospitalier Universitaire Dijon (1)  ·  CytoSorbents, Inc (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  Guillaume BESCH (1)  ·  Hospices Civils de Lyon (1)

Countries

France (13)  ·  United States (6)  ·  Germany (5)  ·  Brazil (3)  ·  Australia (2)  ·  China (2)  ·  Poland (2)  ·  Spain (2)  ·  Austria (1)  ·  Canada (1)  ·  Egypt (1)  ·  Hungary (1)  ·  India (1)  ·  Italy (1)  ·  Mexico (1)

Top investigators

Alexander Zarbock, MD (4)  ·  Bianca Meneguini (1)  ·  Choy Lewis, MD (1)  ·  Dina Badre, MD (1)  ·  Duska Dragun, MD (1)  ·  Edecio Cunha-Neto (1)  ·  Erica D Wittwer (1)  ·  Guillaume Besch, M.D., Ph.D. (1)  ·  James A. Nelson, M.B.B.S. (1)  ·  Jingyuan Xu, M.D. (1)

Results publications

PMID 11588440, PMID 12500513, PMID 15821641, PMID 16134766, PMID 16731105, PMID 19406978, PMID 19948019, PMID 20109575, PMID 23845791, PMID 24151551, PMID 24940436, PMID 25286986, PMID 26492477, PMID 26953217, PMID 28120005, PMID 28327122, PMID 28528561, PMID 29077618, PMID 29223724, PMID 29509568, PMID 30407370, PMID 30653055, PMID 31107279, PMID 31142242, PMID 31334462, PMID 31723628, PMID 31950979, PMID 32028998, PMID 32145658, PMID 32520577, PMID 32609011, PMID 32882250, PMID 32882263, PMID 3303534, PMID 33231111, PMID 33320784, PMID 33564993, PMID 33648544, PMID 33976254, PMID 34017263, PMID 34166293, PMID 34391450, PMID 35171852, PMID 35246227, PMID 35915923, PMID 36012398, PMID 36117167, PMID 36123067, PMID 36524274, PMID 36930693

NIH funding

2014 (1), 2015 (1), 2025 (1)